NCT04442646 Role of "Asthma School" in Disease Management
| NCT ID | NCT04442646 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istituti Clinici Scientifici Maugeri SpA |
| Condition | Asthma |
| Study Type | INTERVENTIONAL |
| Enrollment | 92 participants |
| Start Date | 2019-04-01 |
| Primary Completion | 2026-12-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 92 participants in total. It began in 2019-04-01 with a primary completion date of 2026-12-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
According to the definition provided by the GINA guidelines, asthma is characterized by a variable and reversible limitation of expiratory airflow and by the following symptoms: wheezing, dyspnoea, thoracic constriction and/or cough. The type and the severity of airflow limitation can vary over time (1) depending on external agents, such as physical exercise, polluting agents, climate changes and viral infections. The therapy is mainly based on the use of inhaled corticosteroids and bronchodilators. Patients affected by severe asthma (\~ 10% of total prevalence of asthma and at high risk of exacerbations and/or hospitalization) may not control their symptoms, even if exposed to maximal doses of inhalation therapy.The behavioural sciences can potentially help to find the psychological factors behind scarce adherence and to develop strategies with the aim of improving the interactive processes between patients, medical doctors and health care professionals
Eligibility Criteria
Inclusion Criteria: * Asthma diagnosis according to GINA / ATS guidelines. * Age ≥18 years Exclusion Criteria: •cognitive impairment
Contact & Investigator
Antonio Spanevello, Prof
PRINCIPAL INVESTIGATOR
ICS Maugeri
Frequently Asked Questions
Who can join the NCT04442646 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Asthma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04442646 currently recruiting?
Yes, NCT04442646 is actively recruiting participants. Contact the research team at dina.visca@icsmaugeri.it for enrollment information.
Where is the NCT04442646 trial being conducted?
This trial is being conducted at Tradate, Italy.
Who is sponsoring the NCT04442646 clinical trial?
NCT04442646 is sponsored by Istituti Clinici Scientifici Maugeri SpA. The principal investigator is Antonio Spanevello, Prof at ICS Maugeri. The trial plans to enroll 92 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.